|
|
||||||||
1 Department of Medicine,
Epithelial cells
lining the adult human colon do not normally express gastrin-releasing
peptide (GRP) or its receptor (GRPR). In contrast, approximately
one-third of human colon cancers and cancer cell lines have been shown
to express GRP-binding sites. Because GRPR activation causes the
proliferation of many cancer cell lines, GRP has been presumed to act
as a clinically significant growth factor. Yet GRP has not been shown
to be expressed by colon cancers in humans nor has the effect of GRP
and/or GRPR coexpression on tumor behavior been investigated.
We therefore determined GRP and GRPR expression by immunohistochemistry
in 50 randomly selected colon cancers resected between 1980 and 1997, all 37 associated lymph node and liver metastases, and 20 polyps. Tumor
sections studied were those that contained the margin and adjacent
nonmalignant epithelium. Overall, 84% of cancers aberrantly expressed
GRP or GRPR, with 62% expressing both ligand and receptor, whereas
expression was not observed in adjacent normal epithelium. Consistent
with the previously established mitogenic capabilities of GRP, tissues coexpressing GRP and GRPR were more likely to express proliferating cell nuclear antigen than tissues not expressing both ligand and receptor. Yet GRP/GRPR coexpression was seen with equal frequency in
stage A as in stage D cancers and was only detected in 1 in 37 metastases. Furthermore, Kaplan-Meier analysis did not reveal any
difference in patient survival between those whose tumors did or did
not express GRP/GRPR. In contrast, GRP/GRPR coexpression was found in
all well-differentiated tumor regions, whereas poorly differentiated
tissues never coexpressed GRP/GRPR. Overall, these data indicate that,
although GRP is a mitogen, it is not a clinically significant growth
factor in human colon cancers. Rather, the strong association of
GRP/GRPR coexpression with tumor differentiation raises the possibility
that these proteins primarily act in vivo as morphogens.
adenocarcinoma; bombesin; mitogen; morphogen
This article has been cited by other articles:
![]() |
L. Taglia, D. Matusiak, K. A. Matkowskyj, and R. V. Benya Gastrin-releasing peptide mediates its morphogenic properties in human colon cancer by upregulating intracellular adhesion protein-1 (ICAM-1) via focal adhesion kinase Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G182 - G190. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Glover, R. Nathaniel, L. Shakir, C. Perrault, R. K. Anderson, R. Tran-Son-Tay, and R. V. Benya Transient upregulation of GRP and its receptor critically regulate colon cancer cell motility during remodeling Am J Physiol Gastrointest Liver Physiol, June 1, 2005; 288(6): G1274 - G1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Matusiak, S. Glover, R. Nathaniel, K. Matkowskyj, J. Yang, and R. V. Benya Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon Am J Physiol Gastrointest Liver Physiol, April 1, 2005; 288(4): G718 - G728. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Matkowskyj, R. Cox, R. T. Jensen, and R. V. Benya Quantitative Immunohistochemistry by Measuring Cumulative Signal Strength Accurately Measures Receptor Number J. Histochem. Cytochem., February 1, 2003; 51(2): 205 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Saurin, M. Fallavier, B. Sordat, J.-C. Gevrey, J.-A. Chayvialle, and J. Abello Bombesin Stimulates Invasion and Migration of Isreco1 Colon Carcinoma Cells in a Rho-dependent Manner Cancer Res., August 15, 2002; 62(16): 4829 - 4835. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Lango, K. F. Dyer, V. W. Y. Lui, W. E. Gooding, C. Gubish, J. M. Siegfried, and J. R. Grandis Gastrin-Releasing Peptide Receptor-Mediated Autocrine Growth in Squamous Cell Carcinoma of the Head and Neck J Natl Cancer Inst, March 6, 2002; 94(5): 375 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Carroll, D. Ostrovskiy, S. Lee, A. Danilkovich, and R. V. Benya Characterization of Gastrin-Releasing Peptide and Its Receptor Aberrantly Expressed by Human Colon Cancer Cell Lines Mol. Pharmacol., September 1, 2000; 58(3): 601 - 607. [Abstract] [Full Text] |
||||
![]() |
R. E. Carroll, K. A. Matkowskyj, M. S. Tretiakova, J. F. Battey, and R. V. Benya Gastrin-releasing Peptide Is a Mitogen and a Morphogen in Murine Colon Cancer Cell Growth Differ., July 1, 2000; 11(7): 385 - 393. [Abstract] [Full Text] |
||||
![]() |
K. A. Matkowskyj, D. Schonfeld, and R. V. Benya Quantitative Immunohistochemistry by Measuring Cumulative Signal Strength Using Commercially Available Software Photoshop and Matlab J. Histochem. Cytochem., February 1, 2000; 48(2): 303 - 312. [Abstract] [Full Text] |
||||
![]() |
Y.-S. Guo, M. R. Hellmich, X. D. Wen, and C. M. Townsend Jr. Activator Protein-1 Transcription Factor Mediates Bombesin-stimulated Cyclooxygenase-2 Expression in Intestinal Epithelial Cells J. Biol. Chem., June 15, 2001; 276(25): 22941 - 22947. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |